OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Advancing the Science of Pharmaceutical Manufacturing
Collaboration and new tools aid efforts to implement new processing technologies for small-molecule drug product manufacturing.
Experts discuss what data to consider when selecting a high-potential drug candidate.
Effective cleaning and disinfection along with contamination controls is imperative when operating and utilizing a cleanroom.
Data may be used to improve (or remove) a corrective action/preventive action.
The booming cell therapy market has created a need for capacity that outsourcing partners are ready to fill.
Biologic Drug Development and Manufacturing
May 18, 2022
Pfizer and BioNTech’s COVID-19 vaccine has been granted EUA for booster doses in children five through 11 years of age.
The companies have reached an agreement with the European Commission to update their COVID-19 vaccine supply agreement.
May 17, 2022
In this episode of the Drug Solutions Podcast, Chris Spivey, editorial director, interviews Michael Kopcha, Sau Lee, and Cindy Buhse of FDA about not being afraid to try new approaches and how they invite fresh ideas and abundant communication.
May 16, 2022
Avacta is relocating its therapeutics headquarters to Scale Space in Imperial College’s White City Campus, London, United Kingdom.
Pfizer will acquire Biohaven Pharmaceuticals, a clinical-stage biopharmaceutical company specializing in migraine treatments, for $11.7 billion.
Innovations address sustainability, serialization, and supply-chain issues.
By following some fundamental steps, manufacturers can optimize their tablet tooling maintenance and resulting productivity.
The struggle to implement continuous biomanufacturing at GMP level is slowly advancing.
May 13, 2022
Through a collaboration, Avantor and Cytovance Biologics will accelerate plasmid optimization and sourcing services for viral vectors and mRNA-based vaccines and therapeutics.
May 12, 2022
PCI Pharma Services is investing $100 million in manufacturing capabilities and capacity expansion to its Bedford, NH facility.